Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
Recruiting
N/A
Interventional Study
Rheumatic Arthritis
Rheumatoid Arthritis (RA) Prevention
Inflamation
Antioxidant
Anti Oxidative Stress
Anti Aging
C Reactive Protein
Methotrexate
Quality of Life Outcomes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 118 (estimated)
- Sponsor
- Ain Shams University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the current study is to evaluate the effects of resveratrol on the clinical outcome(s) of patients with moderate rheumatoid arthritis.
Objectives :
1. To investigate the effects of Resveratrol on inflammation and oxidative stress by measuring:
* Serum Sirtuin 1(SIRT1)
* Serum Myeloperoxidase (MPO)
* Serum C-reactive protein (CRP)
2. To investigate the effects of Resveratrol …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients \> 18 years old
* Established diagnosis of RA according to American College of Rheumatology/European league Against Rheumatism (ACR/EULAR) 2010 criteria (Aletaha et al., 2010), presented with moderate to high disease activity identified as disease activity score…
Contacts